SCHEMBL27306775

SCHEMBL27306775

CCCN(CC)CC(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 1/20 0.33
▸ AR P10275 1/20 0.33
▸ KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18976847 0.89 MME (0.35) MMEAR
SCHEMBL12570436 0.85 CA12 (0.34) KCNH2
SCHEMBL6262239 0.83 — —
SCHEMBL24316025 0.83 — —
Ammonia Solution, Strong SCHEMBL10555244 0.80 — —
SCHEMBL32665282 0.80 — —
SCHEMBL29341675 0.80 CA12 (0.33) —
SCHEMBL20887301 0.78 CYP1A2 (0.37) MMEAR
SCHEMBL24619672 0.77 CHRM2 (0.30) —
SCHEMBL12570492 0.77 MEN1 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024039883-A2 COMPOSITIONS AND METHODS TO TREAT MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS TRANSLATIONAL DRUG DEVELOPMENT LLC (US) 2024-02-22 — — WO disclosed
Send feedback